A biopharmaceutical company Trevena (NASDAQ: TRVN) will take part in JMP Securities CNS Forum on August 19 – 20, 2020. Carrie Bourdow, President and Chief Executive Officer, will chat online regarding issues of the central nervous system (CNS) disorders.
After announcing the virtual meeting, TRVN started surging by one percent. Perhaps at the end of the day, the change might be 10% as many investors stay alert.
The daily volume rose nearly to six million shares while the average volume is 7,785,012 shares. Short term investors should take a look at TRVN since it is still penny stock that could blast off instantly by any good news regarding CNS.